Active, not recruitingNCT05797896
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
Studying Familial anetoderma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Complement Therapeutics
- Principal Investigator
- Marta UgarteManchester Royal Eye Hospital
- Enrollment
- 250 target
- Eligibility
- 65 years · All sexes
- Timeline
- 2023 – 2027
Study locations (22)
- Global Research Management, Glendale, California, United States
- Northern California Retina Vitreous Associates, Mountain View, California, United States
- Midwest Eye Institute, Carmel, Indiana, United States
- Mid Atlantic Retina Specialists, Hagerstown, Maryland, United States
- Sierra Eye Associates, Reno, Nevada, United States
- Verum Research LLC, Eugene, Oregon, United States
- Mid Atlantic Retina, Philadelphia, Pennsylvania, United States
- Retina Research Institute of Texas, Abilene, Texas, United States
- Texas Retina Associates, Plano, Texas, United States
- San Antonio Eye Center, San Antonio, Texas, United States
- Belfast City Hospital, Belfast, United Kingdom
- Bradford Royal Infirmary, Bradford, United Kingdom
- Frimley Park Hospital, Frimley, United Kingdom
- Gloucestershire Royal Hospital, Gloucester, United Kingdom
- Liverpool Hospital, Liverpool, United Kingdom
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05797896 on ClinicalTrials.gov